XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 8 Months Ended
Sep. 10, 2017
Sep. 11, 2016
Cash flows from operating activities:    
Net income $ 184,578 $ 141,945
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 30,054 25,460
Losses on sale/disposal of assets 648 473
Amortization of debt issuance costs 9,424 4,562
Provision for deferred income taxes 5,680 2,657
Non-cash compensation expense 14,271 12,344
Other 234 (406)
Excess tax benefits from equity-based compensation (20,430) (41,479)
Changes in operating assets and liabilities (2,321) 17,061
Net cash provided by operating activities 222,138 162,617
Cash flows from investing activities:    
Capital expenditures (38,897) (38,254)
Changes in restricted cash (65,505) 57,371
Other 327 2,989
Net cash provided by (used in) investing activities (104,075) 22,106
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 1,900,000 63,000
Repayments of long-term debt and capital lease obligations (920,093) (77,592)
Proceeds from exercise of stock options 4,014 12,324
Excess tax benefits from equity-based compensation   41,479
Purchases of common stock (1,012,721) (283,858)
Tax payments for restricted stock upon vesting (9,386) (5,605)
Payments of common stock dividends and equivalents (44,630) (37,548)
Cash paid for financing costs (16,846) 0
Other (205) 0
Net cash used in financing activities (99,867) (287,800)
Effect of exchange rate changes on cash and cash equivalents 349 (391)
Change in cash and cash equivalents 18,545 (103,468)
Cash and cash equivalents, at beginning of period 42,815 [1] 133,449
Cash and cash equivalents, at end of period $ 61,360 $ 29,981
[1] Note: The balance sheet at January 1, 2017 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.